Loading data for SRZN — first visit, this takes a few seconds.
Surrozen, Inc. (SRZN)
NasdaqCM: SRZN
· Real-Time Price · USD
22.54
-0.06 (-0.27%)
At close: Sep 11, 2026, 8:00 PM
19.00
+0.00%
After-hours: 4:10 PM
The price, the headline numbers and the latest news, in one place.
Surrozen, Inc. (SRZN) Stock Price, Analysis & Data
No data available
| Bid | 16.36 |
| Market Cap | 223M |
| Revenue (ttm) | 11.5M |
| Net Income (ttm) | -325M |
| 0.56 | |
| -40.06 | |
| n/a | |
| -4.54 | |
| P/B (ttm) | -1.02 |
| P/S (ttm) | 19.40 |
| Earnings Date | n/a |
| Ask | 28.69 |
| Volume | 200,873 |
| Avg. Volume (20D) | 209,611 |
| Open | 22.92 |
| Previous Close | 22.60 |
| Day's Range | 22.24 - 22.99 |
| 52-Week Range | 11.25 - 35.00 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SRZN
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascul...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 11, 2021
Employees 44
Stock Exchange NasdaqCM
Ticker Symbol SRZN
Website https://www.surrozen.com
Financial Performance
In 2025, Surrozen's revenue was 3.48M, a decrease of -67.37% compared to the previous year's 10.66M. Earnings were -242.03M, an increase of 280.76%.
Financial StatementsEarnings Surprise
Surrozen has released their quarterly earnings on Aug 6, 2026:
- Revenue of $5M misses estimates by $0, with 408.65% YoY growth.
- EPS of -2.1 misses estimates by -0.84, with -84.21% YoY decline.
Page 1 of 2